Abstract: 〔Abstract〕 Objective To investigate the clinical and pathological characteristics of 33 cases of fumarate hydratase (FH)-deficient uterine leiomyoma in Fuzhou area. Methods A total of 33 patients with FH-deficient uterine leiomyoma admitted to Fujian Provincial Hospital and South Branch from January 2018 to April 2022 were retrospectively analyzed. Another 64 patients with common uterine leiomyoma were selected, and the morphological, immunohistochemical, genetic and other clinical characteristics of 33 patients with FH-deficient uterine leiomyoma were compared and analyzed. Results The incidence of renal mass in patients with FH-deficient uterine leiomyoma was 24.24 %, higher than 6.25 % in patients with common uterine leiomyoma. FH-negative rate and 2-succino-cysteine (2SC) positive rate were higher than those in patients with common uterine leiomyoma. The strong positive rate of (Actin) (SM), medium/strong positive rate of Desmin expressed by muscle tissue tumors, weak positive rate of CD10, and strong positive rate of smooth muscle and myoepithelial cells (H-caldesmon) were lower than those of normal uterine leiomyoma patients, and the differences were statistically significant (P < 0.05). All patients with FH-deficient uterine leiomyoma survived until May 2022, and 1 patient relapsed without metastasis of fibroid cells. Conclusion FH-deficient uterine leiomyomas have unique morphological characteristics, immunophenotype and pathological characteristics, and early genetic counseling and screening, and FH detection are particularly important.